122 related articles for article (PubMed ID: 37715313)
1. Temporal trend in survival for chronic myelomonocytic leukemia in the US: a population-based study.
Lesegretain A; Brunner A; Benzohra A; Fathi AT
Leuk Lymphoma; 2023 Dec; 64(13):2156-2164. PubMed ID: 37715313
[TBL] [Abstract][Full Text] [Related]
2. Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries.
Benzarti S; Daskalakis M; Feller A; Bacher VU; Schnegg-Kaufmann A; Rüfer A; Holbro A; Schmidt A; Benz R; Solenthaler M; Stussi G; Arndt V; Bonadies N;
Cancer Epidemiol; 2019 Apr; 59():51-57. PubMed ID: 30690330
[TBL] [Abstract][Full Text] [Related]
3. Incidence and survival outcomes of chronic myelomonocytic leukemia in the United States.
Guru Murthy GS; Dhakal I; Mehta P
Leuk Lymphoma; 2017 Jul; 58(7):1648-1654. PubMed ID: 27881041
[TBL] [Abstract][Full Text] [Related]
4. Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): a population-based study, 1993-2007.
Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Solé F; Marcos-Gragera R
Leuk Res; 2012 Oct; 36(10):1262-6. PubMed ID: 22784713
[TBL] [Abstract][Full Text] [Related]
5. Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based study.
Zeidan AM; Hu X; Long JB; Wang R; Ma X; Podoltsev NA; Huntington SF; Gore SD; Davidoff AJ
Cancer; 2017 Oct; 123(19):3754-3762. PubMed ID: 28621841
[TBL] [Abstract][Full Text] [Related]
6. Changes of the energetic profile in masters' swimmers over a season.
Ferreira MI; Barbosa TM; Neiva HP; Vilaça-Alves J; Costa MJ; Marinho DA
J Sports Med Phys Fitness; 2015 Dec; 55(12):1509-16. PubMed ID: 25359133
[TBL] [Abstract][Full Text] [Related]
7. Second malignancies in survivors of chronic myelomonocytic leukemia: a U.S. population-based study.
El-Fattah MA
Leuk Lymphoma; 2017 Sep; 58(9):1-7. PubMed ID: 28092999
[No Abstract] [Full Text] [Related]
8. Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults.
Zandberg DP; Huang TY; Ke X; Baer MR; Gore SD; Smith SW; Davidoff AJ
Haematologica; 2013 Apr; 98(4):584-90. PubMed ID: 23144192
[TBL] [Abstract][Full Text] [Related]
9. High leukemia-free survival after TBI-based conditioning and mycophenolate mofetil-containing immunosuppression in patients allografted for chronic myelomonocytic leukemia: a single-center experience.
Radujkovic A; Hegenbart U; Müller-Tidow C; Herfarth K; Dreger P; Luft T
Ann Hematol; 2020 Apr; 99(4):855-866. PubMed ID: 32036420
[TBL] [Abstract][Full Text] [Related]
10. Blastic Transformation in Mexican Population With Chronic Myelomonocytic Leukemia.
Rivera Duarte A; Armengol Alonso A; Sandoval Cartagena E; Tuna Aguilar E
Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):532-538. PubMed ID: 28842140
[TBL] [Abstract][Full Text] [Related]
11. Perioperative cytokines during orthotopic liver transplantation without venovenous bypass.
Faybik P; Hetz H; Krenn CG; Baker A; Berlakovich GA; Steltzer H
Transplant Proc; 2003 Dec; 35(8):3019-21. PubMed ID: 14697966
[TBL] [Abstract][Full Text] [Related]
12. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
[TBL] [Abstract][Full Text] [Related]
13. Prognostic assessment for chronic myelomonocytic leukemia in the context of the World Health Organization 2016 proposal: a multicenter study of 280 patients.
González JS; Perusini MA; Basquiera AL; Alfonso G; Fantl D; Lima WM; Nucifora E; Lazzarino C; Novoa V; de Andrade Silva MC; Larripa IB; Rocha V; Arbelbide J; Velloso EDRP; Belli CB
Ann Hematol; 2021 Jun; 100(6):1439-1449. PubMed ID: 33932168
[TBL] [Abstract][Full Text] [Related]
14. Muscle mass change during chemotherapy in children with high-risk neuroblastoma: a retrospective case series of 24 patients.
Nakamura N; Kishimoto K; Ishida T; Nakamura S; Tamura A; Kozaki A; Saito A; Hasegawa D; Kosaka Y
Eur J Pediatr; 2021 Nov; 180(11):3265-3271. PubMed ID: 33970314
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.
Park S; Labopin M; Yakoub-Agha I; Delaunay J; Dhedin N; Deconinck E; Michallet M; Robin M; De Revel T; Bernard M; Vey N; Lioure B; Lapusan S; Tabrizi R; Bourhis JH; Huynh A; Beguin Y; Socié G; Dreyfus F; Fenaux P; Mohty M
Eur J Haematol; 2013 May; 90(5):355-64. PubMed ID: 23320648
[TBL] [Abstract][Full Text] [Related]
16. The clinical management of chronic myelomonocytic leukemia.
Padron E; Komrokji R; List AF
Clin Adv Hematol Oncol; 2014 Mar; 12(3):172-8. PubMed ID: 24927265
[TBL] [Abstract][Full Text] [Related]
17. Does lymphocyte-to-monocyte ratio before, during, or after definitive chemoradiation for locally advanced pancreatic cancer predict for clinical outcomes?
Giacomelli I; Scartoni D; Mohammadi H; Regine WF; Chuong MD
J Gastrointest Oncol; 2017 Aug; 8(4):721-727. PubMed ID: 28890823
[TBL] [Abstract][Full Text] [Related]
18. Pulp vitality in patients with intraoral and oropharyngeal malignant tumors undergoing radiation therapy assessed by pulse oximetry.
Kataoka SH; Setzer FC; Gondim-Junior E; Pessoa OF; Gavini G; Caldeira CL
J Endod; 2011 Sep; 37(9):1197-200. PubMed ID: 21846533
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group.
Wattel E; Guerci A; Hecquet B; Economopoulos T; Copplestone A; Mahé B; Couteaux ME; Resegotti L; Voglova V; Foussard C; Pegourié B; Michaux JL; Deconinck E; Stoppa AM; Mufti G; Oscier D; Fenaux P
Blood; 1996 Oct; 88(7):2480-7. PubMed ID: 8839839
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.
Pleyer L; Leisch M; Kourakli A; Padron E; Maciejewski JP; Xicoy Cirici B; Kaivers J; Ungerstedt J; Heibl S; Patiou P; Hunter AM; Mora E; Geissler K; Dimou M; Jimenez Lorenzo MJ; Melchardt T; Egle A; Viniou AN; Patel BJ; Arnan M; Valent P; Roubakis C; Bernal Del Castillo T; Galanopoulos A; Calabuig Muñoz M; Bonadies N; Medina de Almeida A; Cermak J; Jerez A; Montoro MJ; Cortés A; Avendaño Pita A; Lopez Andrade B; Hellstroem-Lindberg E; Germing U; Sekeres MA; List AF; Symeonidis A; Sanz GF; Larcher-Senn J; Greil R
Lancet Haematol; 2021 Feb; 8(2):e135-e148. PubMed ID: 33513373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
